{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T21:50:55Z","timestamp":1766267455775,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST-105-2628-B-195-001-MY3"],"award-info":[{"award-number":["MOST-105-2628-B-195-001-MY3"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1112-7","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T14:47:14Z","timestamp":1560437234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cardiac characteristics and natural progression in Taiwanese patients with mucopolysaccharidosis III"],"prefix":"10.1186","volume":"14","author":[{"given":"Hsiang-Yu","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Ren","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-Miao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Lieh","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dau-Ming","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tung-Ming","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Kuang","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuan-Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,13]]},"reference":[{"key":"1112_CR1","unstructured":"Neufeld EF, Muenzer J: The mucoplysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The metabolic and molecular bases of inherited disease, 8th edn. New York: McGraw-Hill; 2001, 3421\u20133452."},{"key":"1112_CR2","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s004310050872","volume":"157","author":"JH Dangel","year":"1998","unstructured":"Dangel JH. Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders--clinical and echocardiographic findings in 64 patients. Eur J Pediatr. 1998;157:534\u20138.","journal-title":"Eur J Pediatr"},{"key":"1112_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1017\/S1047951109003576","volume":"19","author":"V Fesslov\u00e1","year":"2009","unstructured":"Fesslov\u00e1 V, Corti P, Sersale G, Rovelli A, Russo P, Mannarino S, et al. The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses. Cardiol Young. 2009;19:170\u20138.","journal-title":"Cardiol Young"},{"key":"1112_CR4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/j.1651-2227.2002.tb03330.x","volume":"91","author":"UR Mohan","year":"2002","unstructured":"Mohan UR, Hay AA, Cleary MA, Wraith JE, Patel RG. Cardiovascular changes in children with mucopolysaccharide disorders. Acta Paediatr. 2002;91:799\u2013804.","journal-title":"Acta Paediatr"},{"key":"1112_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/BF01991908","volume":"154","author":"CF Wippermann","year":"1995","unstructured":"Wippermann CF, Beck M, Schranz D, Huth R, Michel-Behnke I, J\u00fcngst BK. Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses. Eur J Pediatr. 1995;154:98\u2013101.","journal-title":"Eur J Pediatr"},{"key":"1112_CR6","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","volume":"34","author":"EA Braunlin","year":"2011","unstructured":"Braunlin EA, Harmatz PR, Scarpa M, Furlanetto B, Kampmann C, Loehr JP, et al. Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management. J Inherit Metab Dis. 2011;34:1183\u201397.","journal-title":"J Inherit Metab Dis"},{"key":"1112_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1017\/S104795110999062X","volume":"20","author":"GN Leal","year":"2010","unstructured":"Leal GN, de Paula AC, Leone C, Kim CA. Echocardiographic study of paediatric patients with mucopolysaccharidosis. Cardiol Young. 2010;20:254\u201361.","journal-title":"Cardiol Young"},{"key":"1112_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2143\/AC.60.1.2005049","volume":"60","author":"MR Chen","year":"2005","unstructured":"Chen MR, Lin SP, Hwang HK, Yu CH. Cardiovascular changes in mucopolysaccharidoses in Taiwan. Acta Cardiol. 2005;60:51\u20133.","journal-title":"Acta Cardiol"},{"key":"1112_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10545-011-9444-z","volume":"36","author":"MM Brands","year":"2013","unstructured":"Brands MM, Frohn-Mulder IM, Hagemans ML, Hop WC, Oussoren E, Helbing WA, et al. Mucopolysaccharidosis: cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI. J Inherit Metab Dis. 2013;36:227\u201334.","journal-title":"J Inherit Metab Dis"},{"key":"1112_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ymgme.2014.02.009","volume":"111","author":"SM Lin","year":"2014","unstructured":"Lin SM, Lin HY, Chuang CK, Lin SP, Chen MR. Cardiovascular abnormalities in Taiwanese patients with mucopolysaccharidosis. Mol Genet Metab. 2014;111:493\u20138.","journal-title":"Mol Genet Metab"},{"key":"1112_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ymgme.2016.02.003","volume":"117","author":"HY Lin","year":"2016","unstructured":"Lin HY, Chuang CK, Chen MR, Lin SM, Hung CL, Chang CY, et al. Cardiac structure and function and effects of enzyme replacement therapy in patients with mucopolysaccharidoses I, II, IVA and VI. Mol Genet Metab. 2016;117:431\u20137.","journal-title":"Mol Genet Metab"},{"key":"1112_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13023-018-0883-6","volume":"13","author":"HY Lin","year":"2018","unstructured":"Lin HY, Chen MR, Lin SM, Hung CL, Niu DM, Chuang CK, et al. Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with mucopolysaccharidosis IVA. Orphanet J Rare Dis. 2018;13:148.","journal-title":"Orphanet J Rare Dis"},{"key":"1112_CR13","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1136\/heartjnl-2015-309258","volume":"102","author":"E Braunlin","year":"2016","unstructured":"Braunlin E, Wang R. Cardiac issues in adults with the mucopolysaccharidoses: current knowledge and emerging needs. Heart. 2016;102:1257\u201362.","journal-title":"Heart"},{"key":"1112_CR14","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.amjcard.2006.02.047","volume":"98","author":"EA Braunlin","year":"2006","unstructured":"Braunlin EA, Berry JM, Whitley CB. Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I. Am J Cardiol. 2006;98:416\u20138.","journal-title":"Am J Cardiol"},{"key":"1112_CR15","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s10545-009-1119-7","volume":"32","author":"SA Jones","year":"2009","unstructured":"Jones SA, Alm\u00e1ssy Z, Beck M, Burt K, Clarke JT, Giugliani R, et al. Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the hunter outcome survey (HOS). J Inherit Metab Dis. 2009;32:534\u201343.","journal-title":"J Inherit Metab Dis"},{"key":"1112_CR16","first-page":"59","volume":"15","author":"C Lavery","year":"2015","unstructured":"Lavery C, Hendriksz C. Mortality in patients with Morquio syndrome A. JIMD Rep. 2015;15:59\u201366.","journal-title":"JIMD Rep"},{"key":"1112_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13023-016-0471-6","volume":"11","author":"HY Lin","year":"2016","unstructured":"Lin HY, Chuang CK, Huang YH, Tu RY, Lin FJ, Lin SJ, et al. Causes of death and clinical characteristics of 34 patients with Mucopolysaccharidosis II in Taiwan from 1995-2012. Orphanet J Rare Dis. 2016;11:85.","journal-title":"Orphanet J Rare Dis"},{"key":"1112_CR18","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1007\/s10545-005-0211-x","volume":"28","author":"HY Lin","year":"2005","unstructured":"Lin HY, Lin SP, Chuang CK, Chen MR, Chen BF, Wraith JE. Mucopolysaccharidosis I under enzyme replacement therapy with laronidase--a mortality case with autopsy report. J Inherit Metab Dis. 2005;28:1146\u20138.","journal-title":"J Inherit Metab Dis"},{"key":"1112_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2147\/TACG.S57672","volume":"8","author":"AO Fedele","year":"2015","unstructured":"Fedele AO. Sanfilippo syndrome: causes, consequences, and treatments. Appl Clin Genet. 2015;8:269\u201381.","journal-title":"Appl Clin Genet"},{"key":"1112_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/1750-1172-8-189","volume":"8","author":"V Delgadillo","year":"2013","unstructured":"Delgadillo V, O'Callaghan Mdel M, Gort L, Coll MJ, Pineda M. Natural history of Sanfilippo syndrome in Spain. Orphanet J Rare Dis. 2013;8:189.","journal-title":"Orphanet J Rare Dis"},{"key":"1112_CR21","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1002\/ajmg.a.40351","volume":"176A","author":"HY Lin","year":"2018","unstructured":"Lin HY, Chuang CK, Lee CL, Tu RY, Lo YT, Chiu PC, et al. Mucopolysaccharidosis III in Taiwan: natural history, clinical and molecular characteristics of 28 patients diagnosed during a 21-year period. Am J Med Genet A. 2018;176A:1799\u2013809.","journal-title":"Am J Med Genet A"},{"key":"1112_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ymgme.2018.04.010","volume":"124","author":"CM Wilhelm","year":"2018","unstructured":"Wilhelm CM, Truxal KV, McBride KL, Kovalchin JP, Flanigan KM. Natural history of echocardiographic abnormalities in mucopolysaccharidosis III. Mol Genet Metab. 2018;124:131\u20134.","journal-title":"Mol Genet Metab"},{"key":"1112_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/jimd.12015","volume":"42","author":"SCM Nijmeijer","year":"2019","unstructured":"Nijmeijer SCM, de Bruin-Bon RHACM, Wijburg FA, Kuipers IM. Cardiac disease in mucopolysaccharidosis type III. J Inherit Metab Dis. 2019;42:276\u201385.","journal-title":"J Inherit Metab Dis"},{"key":"1112_CR24","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ymgmr.2014.09.003","volume":"1","author":"EM Ribeiro","year":"2014","unstructured":"Ribeiro EM, Brusius-Facchin AC, Leistner-Segal S, da Silva CA, Schwartz IV. Cardiac disease as the presenting feature of mucopolysaccharidosis type IIIA: a case report. Mol Genet Metab Rep. 2014;1:422\u20134.","journal-title":"Mol Genet Metab Rep"},{"key":"1112_CR25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/BF00796996","volume":"14","author":"J Muenzer","year":"1993","unstructured":"Muenzer J, Beekman RH, Profera LM, Bove EL. Severe mitral insufficiency in mucopolysaccharidosis type III-B (Sanfilippo syndrome). Pediatr Cardiol. 1993;14:130\u20132.","journal-title":"Pediatr Cardiol"},{"key":"1112_CR26","doi-asserted-by":"publisher","first-page":"e0131662","DOI":"10.1371\/journal.pone.0131662","volume":"10","author":"GG Schiattarella","year":"2015","unstructured":"Schiattarella GG, Cerulo G, De Pasquale V, Cocchiaro P, Paciello O, Avallone L, et al. The murine model of mucopolysaccharidosis IIIB develops cardiopathies over time leading to heart failure. PLoS One. 2015;10:e0131662.","journal-title":"PLoS One"},{"key":"1112_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/jcla.10051","volume":"16","author":"CK Chuang","year":"2002","unstructured":"Chuang CK, Lin SP, Lin SJ, Wang TJ. MPS screening methods, the Berry spot and acid turbidity tests, cause a high incidence of false-negative results in sanfilippo and morquio syndromes. J Clin Lab Anal. 2002;16:253\u20138.","journal-title":"J Clin Lab Anal"},{"key":"1112_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13023-014-0135-3","volume":"9","author":"CK Chuang","year":"2014","unstructured":"Chuang CK, Lin HY, Wang TJ, Tsai CC, Liu HL, Lin SP. A modified liquid chromatography\/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses. Orphanet J Rare Dis. 2014;9:135.","journal-title":"Orphanet J Rare Dis"},{"key":"1112_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233\u201370.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1112_CR30","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.amjcard.2016.11.064","volume":"119","author":"E Einarsen","year":"2017","unstructured":"Einarsen E, Cramariuc D, L\u00f8nnebakken MT, Boman K, Gohlke-B\u00e4rwolf C, Chambers JB, et al. Comparison of frequency of ischemic cardiovascular events in patients with aortic stenosis with versus without asymmetric septal hypertrophy (from the SEAS trial). Am J Cardiol. 2017;119:1082\u20137.","journal-title":"Am J Cardiol"},{"key":"1112_CR31","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.echo.2003.12.005","volume":"17","author":"BW Eidem","year":"2004","unstructured":"Eidem BW, McMahon CJ, Cohen RR, Wu J, Finkelshteyn I, Kovalchin JP, et al. Impact of cardiac growth on Doppler tissue imaging velocities: a study in healthy children. J Am Soc Echocardiogr. 2004;17:212\u201321.","journal-title":"J Am Soc Echocardiogr"},{"key":"1112_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2008.11.029","volume":"22","author":"H Baumgartner","year":"2009","unstructured":"Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic assessment of valve stenosis: EAE\/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22:1\u201323 quiz 101-102.","journal-title":"J Am Soc Echocardiogr"},{"key":"1112_CR33","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/ehjci\/jet105","volume":"14","author":"P Lancellotti","year":"2013","unstructured":"Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013;14:611\u201344.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1112_CR34","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440\u201363.","journal-title":"J Am Soc Echocardiogr"},{"key":"1112_CR35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/heart.83.6.667","volume":"83","author":"C Kampmann","year":"2000","unstructured":"Kampmann C, Wiethoff CM, Wenzel A, Stolz G, Betancor M, Wippermann CF, et al. Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe. Heart. 2000;83:667\u201372.","journal-title":"Heart"},{"key":"1112_CR36","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1161\/CIRCULATIONAHA.107.741157","volume":"117","author":"BJ Foster","year":"2008","unstructured":"Foster BJ, Mackie AS, Mitsnefes M, Ali H, Mamber S, Colan SD. A novel method of expressing left ventricular mass relative to body size in children. Circulation. 2008;117:2769\u201375.","journal-title":"Circulation"},{"key":"1112_CR37","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/mgg3.471","volume":"6","author":"HY Lin","year":"2018","unstructured":"Lin HY, Lee CL, Lo YT, Wang TJ, Huang SF, Chen TL, et al. The relationships between urinary glycosaminoglycan levels and phenotypes of mucopolysaccharidoses. Mol Genet Genomic Med. 2018;6:982\u201392.","journal-title":"Mol Genet Genomic Med"},{"issue":"12","key":"1112_CR38","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.3390\/ijms17122004","volume":"17","author":"M Bolourchi","year":"2016","unstructured":"Bolourchi M, Renella P, Wang RY. Aortic root dilatation in mucopolysaccharidosis I-VII. Int J Mol Sci. 2016;17(12):2004.","journal-title":"Int J Mol Sci"},{"key":"1112_CR39","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.braindev.2016.12.008","volume":"39","author":"R Kato","year":"2017","unstructured":"Kato R, Miyahara H, Kawano T, Matsuzuka A, Noda K, Izumi T. Heparan sulfate storage in the cardiac conduction system triggers atrioventricular block. Brain and Development. 2017;39:418\u201321.","journal-title":"Brain and Development"},{"key":"1112_CR40","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jpeds.2011.01.054","volume":"159","author":"C Kampmann","year":"2011","unstructured":"Kampmann C, Beck M, Morin I, Loehr JP. Prevalence and characterization of cardiac involvement in hunter syndrome. J Pediatr. 2011;159:327\u2013331.e2.","journal-title":"J Pediatr"},{"key":"1112_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jcmg.2010.10.008","volume":"4","author":"MA Konstam","year":"2011","unstructured":"Konstam MA, Kramer DG, Patel AR, Maron MS, Udelson JE. Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging. 2011;4:98\u2013108.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1112_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13023-015-0344-4","volume":"10","author":"NA Al-Sannaa","year":"2015","unstructured":"Al-Sannaa NA, Bay L, Barbouth DS, Benhayoun Y, Goizet C, Guelbert N, et al. Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships. Orphanet J Rare Dis. 2015;10:131.","journal-title":"Orphanet J Rare Dis"},{"key":"1112_CR43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1750-1172-8-147","volume":"8","author":"SP Lin","year":"2013","unstructured":"Lin SP, Lin HY, Wang TJ, Chang CY, Lin CH, Huang SF, et al. A pilot newborn screening program for mucopolysaccharidosis type I in Taiwan. Orphanet J Rare Dis. 2013;8:147.","journal-title":"Orphanet J Rare Dis"},{"key":"1112_CR44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13023-018-0816-4","volume":"13","author":"CK Chuang","year":"2018","unstructured":"Chuang CK, Lin HY, Wang TJ, Huang YH, Chan MJ, Liao HC, et al. Status of newborn screening and follow up investigations for mucopolysaccharidoses I and II in Taiwan. Orphanet J Rare Dis. 2018;13:84.","journal-title":"Orphanet J Rare Dis"},{"key":"1112_CR45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jpeds.2018.09.063","volume":"205","author":"MJ Chan","year":"2019","unstructured":"Chan MJ, Liao HC, Gelb MH, Chuang CK, Liu MY, Chen HJ, et al. Taiwan National Newborn Screening Program by tandem mass spectrometry for mucopolysaccharidoses types I, II, and VI. J Pediatr. 2019;205:176\u201382.","journal-title":"J Pediatr"},{"key":"1112_CR46","doi-asserted-by":"publisher","first-page":"e6887","DOI":"10.1097\/MD.0000000000006887","volume":"96","author":"C Col\u00f3n","year":"2017","unstructured":"Col\u00f3n C, Alvarez JV, Casta\u00f1o C, Gutierrez-Solana LG, Marquez AM, O'Callaghan M, et al. A selective screening program for the early detection of mucopolysaccharidosis: results of the FIND project - a 2-year follow-up study. Medicine (Baltimore). 2017;96:e6887.","journal-title":"Medicine (Baltimore)"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1112-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1112-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1112-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T23:34:22Z","timestamp":1591918462000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1112-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,13]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1112"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1112-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2019,6,13]]},"assertion":[{"value":"19 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Declaration of Helsinki of 1975, as revised in 2000. The Institutional Review Board of Mackay Memorial Hospital approved this study, and written informed consent was obtained from all of the patients or their parents who were included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all of the patients or their parents who were included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}